Danni Cheng

5PUBLICATIONS
39CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 02, 2026
Genetically Proxied Inhibition of Cholesterol-Lowering Drug Targets and Survival in HPV-Positive and Non-HPV-Driven Head and Neck Cancer: A Multicentre MR Study.

|Jun 13, 2024
Molecular and transcriptional basis of bidirectional CD4+ T cell exhaustion in oropharyngeal squamous cell carcinoma.

Danni Cheng, Ke Qiu, Daibo Li

|Feb 22, 2023
Proliferative exhausted CD8+ T cells exacerbate long-lasting anti-tumor effects in human papillomavirus-positive head and neck squamous cell carcinoma.

Danni Cheng, Ke Qiu, Yufang Rao

|Jul 15, 2022
Survival Outcomes Related to Treatment Modalities in Patients With Oropharyngeal Squamous Cell Carcinoma.

Danni Cheng, Yufang Rao, Jianqing Qiu

|Dec 21, 2020
Sinonasal teratocarcinosarcoma: a case report and literature review.

Yu-Fang Rao, Dan-Ni Cheng, Ke Qiu

Pageof 1

Frequent Collaborators

2 joint publications

Yu Zhao

2 joint publications

Jianjun Ren

1 joint publications

Yu-Fang Rao

1 joint publications

Ke Qiu